Literature DB >> 17177302

Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy.

Emanuela Balestrieri1, Sandro Grelli, Claudia Matteucci, Antonella Minutolo, Gabriella d'Ettorre, Fiorella Di Sora, Francesco Montella, Vincenzo Vullo, Stefano Vella, Cartesio Favalli, Beatrice Macchi, Antonio Mastino.   

Abstract

The simultaneous expression of 19 apoptosis-related genes was analyzed by RNA-protection assay in peripheral blood mononuclear cells of HIV-infected patients before and during successful antiretroviral therapy (ART). After 12 months of therapy, the expression of the pro-apoptotic genes FAS, FAS-L, FAF-1, FADD, CASPASE-8, DR3, TRAIL, TNFR-1, TRADD, and BAX was significantly downregulated with respect to time 0, while that of BCL-2, BCL-XL, and MCL-1 was significantly upregulated. The data suggest that inhibition of cell death in HIV-positive patients under successful therapy is the result of a complex network of multifactor signaling, correlated with both death and survival of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177302     DOI: 10.1002/jmv.20768

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.

Authors:  Xue Wang; Jiying Tan; Jiangqin Zhao; Viswannath Ragupathy; Mohan Haleyurgirisetty; Indira Hewlett
Journal:  Mol Cell Biochem       Date:  2014-04-22       Impact factor: 3.396

2.  Upregulation of Apoptosis Pathway Genes in Peripheral Blood Mononuclear Cells of HIV-Infected Individuals with Antiretroviral Therapy-Associated Mitochondrial Toxicity.

Authors:  Yram Foli; Musie Ghebremichael; Min Li; Elijah Paintsil
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.

Authors:  Stephanie M Dillon; Laura J Friedlander; Lisa M Rogers; Amie L Meditz; Joy M Folkvord; Elizabeth Connick; Martin D McCarter; Cara C Wilson
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

4.  Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle.

Authors:  Jin-Nyoung Ho; Ho-Geun Yoon; Chang-Soo Park; Sunoh Kim; Woojin Jun; Ryowon Choue; Jeongmin Lee
Journal:  J Med Food       Date:  2012-09       Impact factor: 2.786

5.  Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs.

Authors:  Yanqin Ren; Szu Han Huang; Amanda B Macedo; Adam R Ward; Winiffer D Conce Alberto; Thais Klevorn; Louise Leyre; Dennis C Copertino; Talia M Mota; Dora Chan; Ronald Truong; Thomas Rohwetter; Paul Zumbo; Friederike Dündar; Doron Betel; Colin Kovacs; Erika Benko; Alberto Bosque; R Brad Jones
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

6.  Beneficial effect of TRAIL on HIV burden, without detectable immune consequences.

Authors:  Brett D Shepard; Davide De Forni; David R McNamara; Andrea Foli; Stacey A Rizza; Roshini S Abraham; Keith Knutson; Peter J Wettstein; Franco Lori; Andrew D Badley
Journal:  PLoS One       Date:  2008-08-28       Impact factor: 3.240

7.  Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.

Authors:  Hemalatha Babu; Anoop T Ambikan; Erin E Gabriel; Sara Svensson Akusjärvi; Alangudi Natarajan Palaniappan; Vijila Sundaraj; Naveen Reddy Mupanni; Maike Sperk; Narayanaiah Cheedarla; Rathinam Sridhar; Srikanth P Tripathy; Piotr Nowak; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.